EYEPOINT PHARMACEUTICALS INC's ticker is EYPT and the CUSIP is 30233G100. A total of 58 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.73 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $406,000 | – | 226,802 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CVI Holdings, LLC | 1,484,714 | $2,658,000 | 2.52% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 549,750 | $984,000 | 0.14% |
| BARD ASSOCIATES INC | 88,184 | $158,000 | 0.08% |
| EAM Investors, LLC | 160,628 | $288,000 | 0.07% |
| Regal Investment Advisors LLC | 193,450 | $346,000 | 0.07% |
| HighTower Advisors, LLC | 5,284,838 | $9,460,000 | 0.06% |
| HIGHLAND CAPITAL MANAGEMENT LP | 545,000 | $976,000 | 0.06% |
| Granite Point Capital Management, L.P. | 329,000 | $589,000 | 0.06% |
| Kore Private Wealth LLC | 104,366 | $187,000 | 0.04% |
| Verition Fund Management LLC | 498,167 | $892,000 | 0.04% |